Cash generation is robust with a 28.8% average FCF margin and cumulative OCF of $1.0B exceeding net income of $626M, but working capital swings (from +$90.5M to -$72.1M) and SBC averaging $28.5M per quarter warrant monitoring.
Dolby Laboratories, Inc. (DLB) cash flow statement — 23-year operating, investing & financing cash flows
| Metric | TTM | Sep'25 | Sep'24 | Sep'23 | Sep'22 | Sep'21 | Sep'20 | Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 | Sep'12 | Sep'11 | Sep'10 | Sep'09 | Sep'08 | Sep'07 | Sep'06 | Sep'05 | Sep'04 | Sep'03 |
|---|
| Cash from Operations | 437.6M | 472.2M | 327.25M | 367.08M | 318.58M | 447.75M | 343.85M | 327.67M | 352.2M | 377.79M | 360.06M | 309.38M | 361.55M | 276.5M | 389.92M | 403.69M | 327.3M | 273.23M | 264.47M | 162.97M | 132.5M | 80.42M | 46.86M | 39.64M |
| Operating CF Margin % | - | 35% | 25.69% | 28.24% | 25.41% | 34.95% | 29.6% | 26.39% | 33.4% | 34.93% | 35.1% | 31.87% | 37.65% | 30.4% | 42.1% | 42.25% | 35.47% | 37.97% | 41.31% | 33.81% | 33.84% | 24.52% | 16.21% | 18.23% |
| Operating CF Growth % | 57.34% | 44.29% | -10.85% | 15.23% | -28.85% | 30.22% | 4.94% | -6.96% | -6.77% | 4.92% | 16.38% | -14.43% | 30.76% | -29.09% | -3.41% | 23.34% | 19.79% | 3.31% | 62.28% | 23% | 64.76% | 71.63% | 18.2% | - |
| Net Income | 226.18M | 256.49M | 264.32M | 201.64M | 183.9M | 317.82M | 231.62M | 255.5M | 42.3M | 207.11M | 186.4M | 183.24M | 208.72M | 190.3M | 265.13M | 310.58M | 282.83M | 244.35M | 199.46M | 142.83M | 89.55M | 52.29M | 39.84M | 30.97M |
| Depreciation & Amortization | 103.31M | 98.6M | 87.33M | 95.51M | 103.61M | 112.76M | 111.88M | 85.12M | 81.28M | 84.31M | 85.15M | 69.13M | 53.28M | 53.24M | 43.88M | 43.99M | 34.94M | 28.73M | 24.81M | 14.48M | 12.95M | 11.35M | 8.52M | 7.5M |
| Stock-Based Compensation | 99.23M | 128.51M | 119.83M | 118.49M | 114.92M | 99.7M | 86.63M | 76.58M | 71.25M | 65.34M | 66.98M | 67.07M | 65.68M | 64.33M | 47.58M | 43.66M | 28.82M | 21.76M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 15.68M | 4.99M | -21.61M | -18.34M | -29.46M | -37.05M | -5.27M | -40.19M | 61.06M | -35.05M | -22.8M | -14.48M | -6.7M | -19.64M | 1.21M | 6.78M | -16.03M | 5.24M | -21.75M | -33.12M | -18.69M | -107K | -10.13M | -2.99M |
| Other Non-Cash Items | 42.19M | 619K | -3.89M | 16.86M | 1.86M | -20.84M | 19.41M | 11.83M | 12.46M | 6.57M | 6.62M | -14.45M | 9.9M | 8.56M | 16.28M | 9.03M | -4.82M | -15.38M | 5.7M | -1.47M | 7.48M | 21.69M | 9.79M | 3.73M |
| Working Capital Changes | -50.27M | -17.01M | -118.71M | -47.08M | -56.25M | -24.64M | -100.42M | -61.18M | 83.85M | 49.51M | 37.7M | 18.86M | 30.66M | -20.29M | 15.84M | -10.36M | 1.57M | -11.47M | 56.25M | 40.25M | 41.22M | -4.81M | -1.16M | 435K |
| Change in Receivables | -37.07M | -1.78M | -37.67M | 48.13M | -8.01M | -70.19M | 35.55M | -57.2M | 97.63M | -62.08M | 24.89M | -7.01M | 10.16M | -53.64M | 18.83M | -8.51M | -31.33M | 1.8M | 987K | -5.01M | 1.29M | -5.13M | -5.92M | -4.8M |
| Change in Inventory | 10.51M | 8.02M | -2.65M | -13.23M | -11.76M | 17.15M | -11.78M | -16.1M | -6.6M | -11.92M | -2.95M | 5.83M | 3.82M | 9.17M | 3.05M | 2.1M | -15.7M | -3.64M | -7.57M | -9.79M | -1.7M | -4.61M | -2.43M | 1.4M |
| Change in Payables | 111.13M | 22.85M | 0 | 0 | 0 | 44.23M | -43.55M | 33.42M | -29.02M | 103.5M | 2.83M | -7.38M | 24.12M | 21.89M | -6.64M | -16.95M | 31.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -76.55M | -10.59M | -286.29M | 54.21M | -295.94M | -44.91M | 134.37M | -56.23M | 78.09M | -158.03M | -282.5M | -203.59M | -204.94M | 175.03M | -194.8M | -236.7M | -44.36M | -236.5M | -271.34M | -192.8M | -163.4M | -31.08M | -30.91M | -14.05M |
| Capital Expenditures | -44.92M | -36.35M | -30.01M | -30.34M | -47.93M | -54.45M | -66.35M | -96.28M | -72.81M | -99.62M | -100.76M | -157.53M | -75.36M | -26.71M | -167.35M | -47.36M | -37.48M | -13.99M | -13.61M | -15.8M | -8.04M | -14.73M | -12.52M | -6.75M |
| CapEx % of Revenue | 3.32% | 2.69% | 2.36% | 2.33% | 3.82% | 4.25% | 5.71% | 7.75% | 6.9% | 9.21% | 9.82% | 16.23% | 7.85% | 2.94% | 18.07% | 4.96% | 4.06% | 1.94% | 2.13% | 3.28% | 2.05% | 4.49% | 4.33% | 3.1% |
| Acquisitions | 0 | -1.36M | -487.88M | 25.7M | -38.17M | -4.5M | 0 | -14.92M | -22.85M | 0 | 0 | -66.3M | 0 | 0 | -12.52M | -3.35M | -5.6M | -16.62M | -253.05M | -30.21M | 0 | -4.59M | -18.44M | -7.05M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -31.55M | 11.29M | 0 | 0 | -11.53M | 16.36M | -2.64M | -17.25M | -12.54M | -5.25M | -121.73M | -38.21M | -36.92M | -5.39M | 1.6M | 3.57M | 1.33M | -9.57M | 40K | 98K | -1.04M | -11.75M | 52K | -250K |
| Cash from Financing | -376.78M | -247.24M | -287.81M | -236.81M | -610.56M | -252.51M | -207.78M | -385.28M | -133.63M | -106.83M | -91.99M | -138.52M | -40.58M | -487.96M | -254.32M | -162.5M | -184.77M | 21.52M | 34.9M | 30.52M | 20.2M | 244.71M | -20K | -1.4M |
| Debt Issued (Net) | 0 | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - | - | - | -79K | -518K | - | -7.68M | -1.52M | -1.54M | -1.47M | -1.36M | -1.29M | -1.24M | -1.4M |
| Equity Issued (Net) | -239.47M | -118.53M | -158.87M | -132.64M | -509.06M | -155.98M | -114.15M | -306.03M | -66.45M | -47.68M | -43.38M | -94.43M | -36.31M | -75.11M | -254.65M | -169.09M | -201.73M | 3.5M | 14.69M | 10.15M | 7.72M | 246.01M | 1.22M | -5K |
| Dividends Paid | -134.25M | -126.6M | -114.58M | -103.41M | -100.07M | -89.17M | -88.58M | -77.5M | -66.16M | -57.06M | -48.4M | -41.02M | 0 | -408.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -269.17M | -162.23M | -199.08M | -180.42M | -566.9M | -278.07M | -196.81M | -363.37M | -172.61M | -117.68M | -114.49M | -123.06M | -69.68M | -91.07M | -272.04M | -197.01M | -244.13M | 0 | 0 | 0 | 0 | -72K | -144K | -38K |
| Other Financing | -3.06M | -2.11M | -14.36M | -766K | -1.44M | -7.36M | -5.04M | -1.76M | -1.02M | -2.09M | -214K | -3.07M | -4.27M | -4.56M | 852K | 6.59M | 24.64M | 19.54M | 21.75M | 21.84M | 13.85M | 0 | 0 | 0 |
| Net Change in Cash | -17.68M | 215.61M | -240.21M | 189.59M | -604.66M | 153.05M | 274.39M | -119.66M | 290.88M | 114.61M | -15.81M | -36.55M | 114.08M | -38.2M | -58.91M | 5.65M | 94.18M | 56.92M | 26.29M | 4.93M | -8.87M | 293.69M | 16.79M | 24.53M |
| Free Cash Flow | 344.5M | 430.26M | 297.25M | 336.74M | 259.12M | 393.3M | 274.86M | 214.14M | 266.85M | 272.93M | 138.28M | 114.44M | 248.23M | 245.74M | 222.22M | 356.33M | 288.99M | 249.66M | 250.86M | 147.17M | 124.46M | 65.69M | 34.34M | 32.89M |
| FCF Margin % | 25.44% | 31.89% | 23.34% | 25.91% | 20.67% | 30.7% | 23.66% | 17.25% | 25.3% | 25.24% | 13.48% | 11.79% | 25.85% | 27.01% | 23.99% | 37.29% | 31.32% | 34.7% | 39.18% | 30.53% | 31.79% | 20.03% | 11.88% | 15.12% |
| FCF Growth % | -21.36% | 44.75% | -11.73% | 29.96% | -34.12% | 43.09% | 28.36% | -19.75% | -2.23% | 97.37% | 20.84% | -53.9% | 1.01% | 10.58% | -37.64% | 23.3% | 15.75% | -0.48% | 70.46% | 18.24% | 89.48% | 91.31% | 4.39% | - |
| FCF per Share | 3.64 | 4.41 | 3.05 | 3.45 | 2.54 | 3.76 | 2.67 | 2.05 | 2.49 | 2.64 | 1.35 | 1.10 | 2.40 | 2.39 | 2.07 | 3.17 | 2.50 | 2.16 | 2.19 | 1.30 | 1.11 | 0.63 | 0.37 | 0.38 |
| FCF Conversion (FCF/Net Income) | 1.52x | 1.85x | 1.25x | 1.83x | 1.73x | 1.44x | 1.49x | 1.28x | 8.44x | 1.87x | 1.94x | 1.71x | 1.75x | 1.46x | 1.48x | 1.31x | 1.15x | 1.12x | 1.33x | 1.14x | 1.48x | 1.54x | 1.18x | 1.28x |
| Interest Paid | 0 | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Taxes Paid | -33.2M | 73.74M | 63.22M | 61.48M | 40.34M | 70.74M | 52.87M | 59.72M | 60.88M | 56.76M | 55.09M | 51.88M | 72.18M | 77.7M | 98.5M | 122.53M | 141.8M | 113.14M | - | - | - | - | - | - |
Quick answers to the most common questions about buying DLB stock.
Dolby Laboratories, Inc. (DLB) generated $472.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Dolby Laboratories, Inc. (DLB) generated $430.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Dolby Laboratories, Inc. (DLB) spent $36.3M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Dolby Laboratories, Inc. (DLB) returned $126.6M to shareholders via cash dividends and spent $162.2M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
AV1 codec adoption threat
Metrics are mathematically derived from official filings.
Cash Conversion Volatility Signals Timing Distortions
Operating cash flow to net income ratio swung from 0.97 in Q2 2026 to 5.85 in Q3 2026, per reported cash flow data, indicating significant timing effects in royalty collections.
The OCF/NI ratio of 5.85 in Q3 2026 is extraordinary, driven by a $90.5M working capital inflow that more than offset a modest $28.6M net income. This suggests that reported earnings are not a reliable indicator of cash generation on a quarterly basis, as royalty receipts often lag and can create lumpy cash flows. Investors should focus on the cumulative cash conversion over multiple quarters rather than any single period.
Free Cash Flow Remains Robust Despite Revenue Stagnation
Free cash flow margin averaged 28.8% over the last ten quarters, with Q3 2026 at 48.4%, as per cash flow data, demonstrating the high cash-generative nature of the licensing model.
Despite erratic revenue growth, FCF has remained consistently positive, with the lowest margin at 4.7% in Q3 2024 and the highest at 48.4% in Q3 2026. This resilience underscores the low capital intensity of the business, but the volatility in FCF margins suggests that quarterly results can be misleading. The cumulative FCF over the period is approximately $968M, which is well above cumulative net income of $626M, indicating strong cash generation relative to accounting earnings.
Minimal Capital Intensity Reflects IP-Led Model
Capital expenditures averaged only 2.7% of revenue over the past ten quarters, per cash flow data, confirming the asset-light nature of Dolby's licensing-centric business.
CapEx has remained consistently low, ranging from 1.3% to 5.3% of revenue, with no significant growth investments. This suggests that the company does not require heavy capital reinvestment to sustain its operations, which is typical for a patent licensing business. The low CapEx also implies that most of the operating cash flow is available for distribution or reinvestment in strategic initiatives like Dolby.io.
Working Capital Swings Reflect Royalty Timing
Working capital changes have swung from a $90.5M inflow in Q3 2026 to a $72.1M outflow in Q2 2026, as per cash flow data, highlighting the lumpy nature of royalty collections.
The large positive working capital change in Q3 2026 likely reflects catch-up payments from licensees or a favorable shift in receivables, while the negative changes in other quarters indicate timing mismatches. This volatility is characteristic of a licensing model where royalty reports arrive with a lag. Investors should not over-interpret quarterly working capital swings but rather assess the trend over a longer horizon.
Consistent Shareholder Returns Outpace Earnings
Dividends and buybacks totaled $1.1B over the last ten quarters, exceeding cumulative net income of $626M, as per cash flow data, indicating a payout ratio above 100%.
The company has returned more cash to shareholders than it has generated in net income, funded by its strong operating cash flow and existing cash reserves. This aggressive capital return policy suggests a mature business with limited high-return internal investment opportunities. However, the sustainability of such payouts depends on continued cash generation, which appears robust given the licensing model.
Cumulative Cash Generation Exceeds Reported Earnings
Over the past ten quarters, cumulative operating cash flow of $1.0B surpassed cumulative net income of $626M, per cash flow data, indicating conservative accounting and high earnings quality.
The persistent gap between operating cash flow and net income, with OCF/NI ratios often above 1.5, suggests that reported earnings understate the company's cash-generative power. This is partly due to non-cash charges like D&A and SBC, which are added back in operating cash flow. The divergence supports the view that Dolby's earnings quality is high, but investors should be aware that the gap can fluctuate due to working capital timing.
What the Cash Flow Statement Obscures
Stock-based compensation averaged $28.5M per quarter over the last ten quarters, per cash flow data, yet it is excluded from operating cash flow, potentially overstating cash generation.
While SBC is a non-cash expense, it represents a real economic cost to shareholders through dilution. The company's reported operating cash flow does not deduct SBC, which may overstate the true cash available to shareholders. Additionally, the $487.9M acquisition in Q4 2024 is not reflected in operating cash flow, and the lack of detail on acquisition-related costs could obscure the true cash efficiency of the business. Investors should adjust for SBC and acquisition impacts when assessing the sustainability of cash returns.